(Q43880703)

27 November 2017

title

Expression and role of the angiotensin II AT2 receptor in human prostate tissue: in search of a new therapeutic option for prostate cancer (English)

1 reference

27 November 2017

10

Nicole Gallo-Payet

1 reference

27 November 2017

1

Marie-Odile Guimond

1 reference

27 November 2017

Marie-Claude Battista

2

object named as

Marie-Claude Battista

0 references

Alexandre A Doueik

6

object named as

Alexandre A Doueik

1 reference

27 November 2017

7

Ladan Fazli

1 reference

27 November 2017

8

Martin Gleave

1 reference

27 November 2017

9

Robert Sabbagh

1 reference

27 November 2017

author name string

Marie-Claude Battista

2

1 reference

27 November 2017

Fatemeh Nikjouitavabi

3

1 reference

27 November 2017

Maude Carmel

4

1 reference

27 November 2017

Véronique Barres

5

1 reference

27 November 2017

publication date

6 February 2013

1 reference

27 November 2017

1 reference

27 November 2017

volume

73

1 reference

27 November 2017

issue

10

1 reference

27 November 2017

page(s)

1057-1068

1 reference

Understanding the epidemiology, natural history, and key pathways involved in prostate cancer

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Prostate cancer: potential targets of anti-proliferative and apoptotic signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Pharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Role of the renin-angiotensin system in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Angiotensin receptors: a new role in cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

The past, present and future of angiotensin II type 2 receptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Renin-angiotensin system is an important factor in hormone refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Synthesis and secretion of angiotensin II by the prostate gland in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Identification, distribution, and expression of angiotensin II receptors in the normal human prostate and benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Inflammation and angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Regulation of angiotensin II receptors in the prostate of the transgenic (mRen-2)27 rat: effect of angiotensin-converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Pilot study of angiotensin II receptor blocker in advanced hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Association between captopril, other antihypertensive drugs and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Angiotensin II type 2 receptor agonists: where should they be applied?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Non-peptide AT2-receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

An ATIPical family of angiotensin II AT2 receptor-interacting proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Expression and function of ATIP/MTUS1 in human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Angiotensin II enhances noradrenaline release from sympathetic nerves of the rat prostate via a novel angiotensin receptor: implications for the pathophysiology of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Co-assessment of cytoplasmic and nuclear androgen receptor location in prostate specimens: potential implications for prostate cancer development and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Fyn is involved in angiotensin II type 2 receptor-induced neurite outgrowth, but not in p42/p44mapk in NG108-15 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT(2)) receptor. Effects on neurite outgrowth in NG108-15 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Transcriptomes of human prostate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Transactivation of ErbB1 and ErbB2 receptors by angiotensin II in normal human prostate stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Angiotensin II blocker decreases serum prostate specific antigen in hormone refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22653

21 January 2018

Identifiers

DOI

10.1002/PROS.22653

1 reference

27 November 2017

1 reference